Semaglutide GLP for Weight Loss – All You Need to Know

In recent times, obesity has surfaced as one of the significant global health challenges. The search for effective and safe weight loss treatment for medical professionals and patients seems never-ending. People suffering from obesity are facing a dilemma in choosing a reliable weight loss treatment. The fact remains that there is no cure for obesity as it requires lifelong treatment that’s not one size fits all.

Indeed the fundamentals of obesity management will always be changes to diet and exercise however having anti-obesity medications is another tool in the toolbox. Depending on the individual clinical history your medical professional will prescribe these medications to you.

If you are an adult who has serious health problems because of your weight it is essential to consult your health care provider. If you have tried diet and exercise but haven't been able to lose enough weight there are prescription medications approved for long-term use to treat overweight and obesity. Prescription drugs are medicines that a health care provider prescribes for you. You can't buy them off the shelf in a drug store like you can buy non-prescription medicines.

However, you must remember that you need to use prescription weight-loss drugs in addition to and NOT instead of a healthy diet and exercise. Your health care provider might suggest a weight-loss drug for you if haven't been able to lose weight through diet and exercise and your:

• Body mass index (BMI) is greater than 30. This means you're living with a condition that involves having too much body fat, called obesity.

• BMI is greater than 27. You also have a serious medical problem linked to obesity, such as diabetes or high blood pressure.

Below we will discuss weight-loss drugs that have been approved by the U.S. Food and Drug Administration (FDA) for long-term use:

1. Semaglutide Staten Island

2. Tirzepatide GLP

3. Wegovy for Weight Loss

4. Zepbound for Weight Loss

Most prescription weight-loss drugs work by making you feel less hungry or fuller. Some do both.

What is Semaglutide Staten Island?

The newest anti-obesity medication known as semaglutide GLP is making waves more than a year after its 2021 approval by the U.S. FDA. Semaglutide Staten Island is an injectable drug, initially only used as diabetes medication. However now it is the first drug approved to treat chronic weight management for adults who are obese or overweight. It is an effective weight loss injectable. It also highlights the value of treating obesity as a chronic metabolic disease instead of expecting people to rely solely on willpower and lifestyle changes to manage their condition.

Here’s what you need to know about semaglutide GLP:

Semaglutide GLP belongs to a class of medications known as glucagon-like peptide-1 receptor agonists, or GLP-1 RAs. It mimics the GLP-1 hormone, released in the gut in response to eating. Among the many roles of GLP-1, the most significant role is to prompt the body to produce more insulin which reduces blood sugar. Hence, healthcare providers have used semaglutide GLP for more than 15 years to treat Type 2 diabetes.

It is found that GLP-1 in higher amounts also interacts with the parts of the brain that suppress your appetite and signal you to feel full. When used in conjunction with diet and exercise Semaglutide Staten Island can cause significant weight loss and a reduced risk of cancer, diabetes and heart diseases in people who are obese or overweight.

How effective are Semaglutide GLP Injections for Weight Loss?

Currently, semaglutide is only approved for weight loss under the brand name Wegovy. Wegovy for weight loss is administered weekly as subcutaneous (under the skin) self-injections. You will find that with growing demand for semaglutide for weight loss, health care professionals are prescribing it under other brands of semaglutide, such as Ozempic and Rybelsus. There are many anti-obesity medications that help suppress appetite and achieve weight loss, however semaglutide GLP performs on a new level.

The different brands of semaglutide (semaglutide injection and semaglutide tablets) have different uses and different forms. Each of the different brands of semaglutide such as Wegovy for weight loss, Ozempic and Rybelus are made by Novo Nordisk and are FDA-approved for different conditions.

What is the Difference between Ozempic, Wegovy for Weight Loss?

Ozempic injection is used to lower blood sugar levels for type two diabetic patients, besides using diet and exercise. It is also used for diabetic patients who already have cardiovascular disease, to help lower the risk of major cardiovascular events such as heart attack or stroke. Ozempic is given as a subcutaneous injection weekly.

Wegovy for weight loss is given as an injection in certain patients and is also used to lower the risk of heart attack, stroke, and cardiovascular death in specific adults. Wegovy is given as a subcutaneous injection weekly.

What is Tirzepatide (Mounjaro, Zepbound)?

There’s a newer medication that can help people who are considered obese or overweight known as Tirzepatide GLP. It is a novel medication approved by the US Food and Drug Administration (FDA) for treating type 2 diabetes mellitus (T2DM) besides this medication also demonstrates efficacy in weight loss, leading to its off-label use for obesity treatment. The drug leads to significantly improved glycaemic control and weight reduction in patients leading to optimal benefits similar to GLP-1 medications such as semaglutide GLP.

Tirzepatide GLP is currently utilized as a second-line diabetes medication akin to GLP-1 drugs, such as semaglutide. Tirzepatide GLP also known as Mounjaro is FDA approved for Type 2 diabetes and it is found that people taking it tend to lose weight. Thus in November 2023, the FDA approved tirzepatide GLP for weight loss in people without diabetes under the brand name Zepbound. Tirzepatide is the first medication in its class and comes as a once-weekly injection. Better known under brand name Zepbound for weight loss it works by impacting your body’s insulin levels, blood glucose (sugar) production, and hunger hormones.

When paired with diet and exercise, tirzepatide GLP can both lower blood glucose levels and lead to significant weight loss in people with diabetes. Most importantly Tirzepatide GLP has been shown to cause weight loss in people without diabetes, too.

How Does Tirzepatide GLP Cause Weight Loss?

It is found that Tirzepatide GLP promotes weight loss by decreasing your appetite and prolonging feelings of fullness. That’s because these effects can cause you to eat fewer calories. The formula for Tirzepatide GLP is unique because it’s the first combination of two classes of medications: a glucagon-like peptide-1 (GLP-1) receptor agonist and a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. Consequently, tirzepatide is known as a dual GLP-1/GIP receptor agonist. Tirzepatide is not just a GLP medication. It is a combination medication of glucagon like polypeptide and glucose dependent insulinotropics polypeptide (GLP/GIP combination).

Tirzepatide signals to your brain that you’re full, slows down digestion, and lowers blood glucose. It may be one of many possible weight loss options. But it may not be right for everyone. Tirzepatide for weight loss is only recommended for people who meet certain BMI criteria. Be sure to talk with your healthcare provider about which option is best for you.

Which Weight Loss Treatment Is The Best Option For Me?

Dr Misra is an expert in the field of medical weight loss. At Misra Wellness, the team specializes in safe, effective weight loss utilizing leading-edge prescription medications. They understand slimming down can be an uphill battle, which is why their team customizes a comprehensive plan based on your unique needs, biomarkers, and goals to optimize and sustain results.